EUVIMEDSkopri EUVIMED
CrossrefKarta ta’ informazzjoni

Management of Immune Thrombocytopenic Patient Associated with COVID-19 Viral Infection: A Case Series

Deniz İNCAMAN

Turkish Journal of Internal Medicine · 2022

DOI: 10.46310/tjim.1009709 ↗
AstrattDettalji biblijografiċi

Astratt

Severe thrombocytopenia is a cause of morbidity and mortality for patients with COVID-19 infection. The common causes of thrombocytopenia in these patients are; sepsis, drug-associated, disseminated intravascular coagulation (DIC), heparin-associated thrombocytopenia (HIT), microangiopathic hemolytic anemia (MAHA). Recently, cases of COVID-19 infection-associated Immune thrombocytopenic purpura (ITP) have been reported in the literature. In our study, we will present our case series consisting of 10 patients associated with COVID-19

Għarfien li jaqbel max-xogħol tiegħek.

Minn bidu b’xejn u riċerka personali tal-letteratura sal-Research Suite sħiħa.

Ara t-tariffi →

Il-full texts kollha tal-pubblikaturi huma inklużi?

Le. Ir-referenzi biblijografiċi, l-astratti u t-testi sħaħ huma kontenuti differenti. Jekk test sħiħ huwiex disponibbli jiddependi mis-sors, Open Access u l-liċenzji eżistenti tiegħek. Pjan ta’ EUVIMED ma jissostitwix drittijiet addizzjonali tal-pubblikaturi.

Ara t-tariffi →